The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumMost Popular - Abbot Labs recorded the first sale of Amitiza in Japan, resulting in a $15M milestone payment to Sucampo on Tuesday. Nevertheless, the thinly-traded equity reacted … Continue Reading
Read nowQuick Picks - A Citizen Petition that Jazz Pharmaceuticals (JAZZ) filed with the FDA in July of 2012 has been rejected, says the company, negating one more barrier … Continue Reading
Read nowLong Ideas - ArQule (NASDAQ:ARQL) has enrolled the first patient in its Phase I trial of the FGFR Inhibitor ARQ-087, the last of five oncology products that the … Continue Reading
Read nowLong Ideas - It’s not easy to do, but buying when there’s blood in the streets is a way many have scored big on Wall Street. Take our … Continue Reading
Read nowLong Ideas - Acadia Pharmaceuticals (NASDAQ:ACAD)Â announced on Wednesday morning a private equity financing to sell 19Â million shares of common stock at $4.43 per share, plus warrants to purchase … Continue Reading
Read nowLong Ideas - Cadence Pharmaceuticals (NASDAQ:CADX) announced that it will terminate its option to acquire privately-held Incline Therapeutics in order for The Medicines Company (NASDAQ:MDCO) to buy Incline … Continue Reading
Read nowLong Ideas - Sucampo Pharmaceuticals (NASDAQ:SCMP) has announced that its commercialization partner for Japan, Abbot Labs (NYSE:ABT), recorded the first sale in the country of Sucampo’s prescription treatment … Continue Reading
Read now
